Try our beta test site
9 studies found for:    Open Studies | Interventional Studies | cancer | intravenous vitamin C
Show Display Options
Rank Status Study
1 Not yet recruiting Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
Condition: Fatigue
Interventions: Drug: Ascorbic Acid;   Other: Normal Saline
2 Not yet recruiting Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Conditions: Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unresectable Pancreatic Carcinoma
Interventions: Drug: Oxaliplatin;   Drug: Irinotecan Hydrochloride;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Dietary Supplement: Ascorbic Acid
3 Not yet recruiting A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   NSCLC
Interventions: Drug: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Ascorbic Acid
4 Recruiting AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer
Condition: Liver Metastases
Intervention: Radiation: AvidinOX/ST2210
5 Recruiting Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Conditions: Glioblastoma;   Glioma
Interventions: Dietary Supplement: Ascorbic Acid;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
6 Not yet recruiting A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: Temozolomide;   Radiation: radiation therapy;   Drug: Ascorbic Acid
7 Recruiting Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
Condition: Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
Interventions: Drug: Sorafenib and irinotecan combination;   Drug: Sorafenib monotherapy;   Drug: Irinotecan monotherapy
8 Recruiting Mature B-Cell Lymphoma And Leukemia Study III
Condition: Mature B-Cell Lymphoma
Interventions: Drug: COPAD;   Drug: COP, COPD M3, CYM;   Drug: COP, COPADM8, CYVE
9 Recruiting Hyper-CVAD Regimen in Sequential Combination With Blinatumomab as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia
Conditions: Leukemia;   Acute Lymphoblastic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: MESNA;   Drug: Dexamethasone;   Drug: Ofatumumab;   Drug: Methotrexate;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cytarabine;   Drug: Rituximab;   Drug: Pegfilgrastim;   Drug: G-CSF;   Drug: Leucovorin;   Drug: Blinatumomab;   Drug: 6-Mercaptopurine;   Drug: Prednisone;   Behavioral: Phone Calls

Study has passed its completion date and status has not been verified in more than two years.